News

News

  • Synexa Life Sciences Expands Bioanalysis Capabilities with the Acquisition of Alderley Analytical

    Synexa Life Sciences BV, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical, an independent bioanalytical Contract Research Organisation (CRO) based in Alderley, UK.

    Read more
  • This is a portrait of Justin Wildgoose, Director of Business Development at Alderley Analytical, wearing a smart casual checked shirt. His direct gaze and pleasant smile convey confidence and approachability, key traits for his role in fostering business growth and partnerships. The natural light accentuates his friendly demeanour, illustrating his approachable nature and professional expertise.

    Not long to go until Justin steps into the ring!

    Alderley Analytical’s Director of Business Development, Justin Wildgoose, is stepping into the ring for the first time on 24th September at a WCF charity event to raise funds for East Cheshire Hospice.

    Read more
  • This image features the logo of Infex Therapeutics, a company specializing in developing treatments for infectious diseases. The logo consists of a stylized

    Infex partners with Alderley Analytical to provide PK and ADA analysis for RESP-X program

    Infex Therapeutics has today announced a deal with Alderley Analytical, to support PK and ADA analysis of Infex’s RESP-X program.

    Read more
  • This image features a promotional graphic for the Alderley Analytical Christmas Bake-off for Charity event. The Alderley Analytical logo is prominently displayed at the top, emphasizing their breakthrough bioanalysis work. The text

    Christmas fundraising meeting in aid of the East Cheshire Hospice

    What do bioanalysts do when not bioanalysing? They have a company-wide, Christmas bake-off for a good cause!

    Read more

Contact us now to learn more

Contact Us